A full-term female neonate who had experienced no birth asphyxia was admitted to our hospital at 12 days of life (D12) due to progressive yellowish skin discoloration of the face, trunk, and all limb regions beginning on D5, followed on subsequent days by frequent vomiting with persistent jaundice. Her birth weight was 2650 gm (25-50th percentile) and body length was 46 cm (10-25th percentile). Family history was unremarkable. She was breastfed exclusively after birth, with adequate changing of diapers. Newborn screening for 17-hydroxyprogesterone and glucose-6-phosphate dehydrogenase was normal.
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On admittance, her weight was 2468 gm (body weight loss of 6.8 %), blood pressure was 58/33 mmHg, heart rate was 188 beats/min, and respiratory rate was 38 breaths/min. Dry skin turgor and icterus were noted. The female external genitalia were normal without hyperpigmentation. Laboratory test results were as follows: serum total bilirubin, 21 mg/dL (normal value <17 mg/dL); direct bilirubin, 0.9 mg/dL (<2 mg/dL); hemoglobin, 18.5 g/dL (15-24 g/dL); aspartate transaminase, Laboratory test results at 24 h after discontinuation of the medical intervention were as follows: blood urea level, 12 mg/ dL (3-12 mg/dL); creatine, 0.5 mg/dL (0.34-0.45 mg/dL); Na, 126 mmol/L; K, 7.2 mmol/L; Cl, 94 mmol/L; glucose, 107 mg/ dL (50-90 mg/dL); serum osmolality, 268 mOsm/kgH 2 O (275-295 mOsm/kgH 2 O); cortisol, 23.49 ug/dL (1-24 ug/dL); plasma renin activity, >50 ng/mL/h (0.5-4.0 ng/mL/h); aldosterone level, >25,000 pg/mL (50-1320 pg/mL). Vein blood gas analysis revealed the following: pH, 7.405 (7.32-7.45); partial pressure carbon dioxide (PCO 2 ), 28.9 mmHg (41-51 mmHg); partial pressure oxygen (PO 2 ), 63.8 mmHg (20-49 mmHg); bicarbonate (HCO 3 ), 17.7 mmol/L (24-28 mmol/L); base excess (BE), −5.3 mmol/L (−10 to −2 mmol/L). Spot urine sampling showed Na at 47 mmol/L, K at 27.9 mmol/L, Cl at 63 mmol/L, and osmolality at 176 mOsm/kgH 2 O. Urinalysis and abdominal sonography were normal.
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Questions
1. What is your diagnostic approach to hyperkalemia? 2. What is the diagnosis? 3. How should this patient be managed?
